Dover Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.28M | Sell |
6,903
-375
| -5% | -$69.6K | 0.56% | 48 |
|
|
2025
Q1 | $1.52M | Sell |
7,278
-286
| -4% | -$59.9K | 0.66% | 43 |
|
|
2024
Q4 | $1.34M | Hold |
7,564
| – | – | 0.77% | 41 |
|
|
2024
Q3 | $1.49M | Sell |
7,564
-585
| -7% | -$116K | 0.85% | 38 |
|
|
2024
Q2 | $1.4M | Sell |
8,149
-99
| -1% | -$17K | 0.86% | 37 |
|
|
2024
Q1 | $1.5M | Buy |
8,248
+2,045
| +33% | +$372K | 1.03% | 30 |
|
|
2023
Q4 | $961K | Sell |
6,203
-1,390
| -18% | -$215K | 1.26% | 25 |
|
|
2023
Q3 | $1.13M | Sell |
7,593
-264
| -3% | -$39.4K | 1.15% | 30 |
|
|
2023
Q2 | $1.06M | Sell |
7,857
-410
| -5% | -$55.2K | 0.94% | 32 |
|
|
2023
Q1 | $1.32M | Buy |
8,267
+1,150
| +16% | +$183K | 1.27% | 27 |
|
|
2022
Q4 | $1.15M | Buy |
+7,117
| New | +$1.15M | 1.24% | 26 |
|